STING1 and breast cancer: Our results support the hypothesis that DOT1L inhibition suppresses breast cancer cell proliferation by activating STING and types I and III IFN signaling, but further study will be necessary to clarify the effect of DOT1L inhibition in TNBC cells with chromosomal instability.